Caplin Point Laboratories (CAPLIPOINT) Share Price rises 2.15% today
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
Caplin Point Laboratories Share Price is trading at Rs 2,659.6, up 2.15% today, with a market capitalisation of Rs 20,008.94 crore. The move places Caplin Point Laboratories Ltd. in focus in the latest Univest view of Caplin Point Laboratories Share Price Today, even though no company-specific catalyst is established. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The stock opened at Rs 2,627.75, touched a high of Rs 2,663.3 and a low of Rs 2,585, which shows the intraday range around the current Caplin Point Laboratories Share Price. For readers tracking Caplin Point Laboratories Stock News, the most useful next checks are the valuation profile, Healthcare peer positioning and whether the price move is reflected in the broader stock analysis picture.
In Univest terms, the day’s share price gain is best read as a price action event first and a fundamentals check second. The Caplin Point Laboratories Share Price is moving within a narrow band near the day high, while the company’s valuation, return ratios and industry comparison provide the deeper context behind today’s attention.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,659.6 |
| Previous Close | Rs 2,603.65 |
| Today's Move | Rs 55.95 (+2.15%) |
| Open | Rs 2,627.75 |
| High | Rs 2,663.3 |
| Low | Rs 2,585 |
| Market Capitalisation | Rs 20,008.94 crore |
| Market Cap Category | Large Cap |
Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,659.6 from the previous close of Rs 2,603.65, a move of Rs 55.95 or 2.15%. The stock opened at Rs 2,627.75, reached a high of Rs 2,663.3, recorded a low of Rs 2,585.
Caplin Point Laboratories Share Price is up Rs 55.95 from the previous close of Rs 2,603.65, marking a 2.15% rise. The stock opened at Rs 2,627.75, moved between Rs 2,585 and Rs 2,663.3, and last traded at Rs 2,659.6. That places the Caplin Point Laboratories Share Price close to the day high and above the opening print, which is the clearest intraday takeaway for readers following Caplin Point Laboratories Share Price Today.
In simple price action terms, the stock is trading higher than the previous close, and the move is large enough to place it among the notable names in the market update for the day. According to latest Univest figures, the rise is real and measurable, but the verified record does not establish a company-specific reason. For anyone scanning Caplin Point Laboratories Share Price Live or Caplin Point Laboratories Share Price Update, the numbers point to a constructive intraday move without extending beyond what the data confirms. The next layer is the Caplin Point Laboratories Fundamental Analysis.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,008.94 crore |
| P/E Ratio | 29.74x |
| P/B Ratio | 5.39x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.31% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 29.74x, P/B 5.39x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 20,008.94 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.74x, P/B at 5.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.74x |
| Benchmark Median P/E | 31.79x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.58x to 668.09x |
| Company P/B Ratio | 5.39x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 20,008.94 crore |
| Benchmark Median Market Cap | Rs 812.84 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 29.74x, which is below the benchmark median of 31.79x, a difference of -6.45%. On its own, the P/E gap is a valuation reference point, not a trading call.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.73%, a difference of +77.24%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.63%, a difference of +83.2%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,34,279.63 | 35.35 | 4.94 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,737.12 | 83.61 | 13.85 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,81,129.27 | 82.93 | 20.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,239.13 | 25.16 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,08,808.05 | 31.97 | 3.07 | 11.83 | 16 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 29.74x compared with the displayed peer median of 35.35x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 20.79% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 20,008.94 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price is up 2.15% today, which places the stock in the day’s active price action discussion.
- The current price of Rs 2,659.6 is near the intraday high of Rs 2,663.3, giving the move clear market relevance.
- ROE of 20.79% and ROCE of 24.97% are both above same-industry medians, which keeps Caplin Point Laboratories Fundamental Analysis in focus.
- P/E of 29.74 is below the industry median of 31.79, while P/B of 5.39 is above the industry median of 2.9.
- Healthcare and Pharmaceuticals & Drugs sector comparison shows a mix of stronger returns and a valuation that deserves close watch in Market News.
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked by investors because Caplin Point Laboratories Share Price combines a sizeable market capitalisation with return ratios that are stronger than the same-industry median. In the latest Univest view, the company stands out more for its financial profile than for any narrative event, which is why Caplin Point Laboratories Stock News often gets read alongside Caplin Point Laboratories Financial Results and Caplin Point Laboratories Stock Performance.
Caplin Point Laboratories Share Price is linked to a business that is assessed through earnings power, book value and valuation multiples rather than through any single day’s move alone. The company’s EPS of 87.53, book value of Rs 483.17 and dividend yield of 0.31% provide a factual backdrop for investors who want to understand how the stock is priced. In the broader Indian Stock Market, that makes the name relevant for comparison with larger Healthcare peers and for anyone following Market Movers in the sector.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price is Rs 2,659.6, up 2.15% today. The stock last traded above the previous close of Rs 2,603.65 and stayed close to the day high of Rs 2,663.3.
Why is Caplin Point Laboratories rising today?
Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Caplin Point Laboratories Share Price rose 2.15%, and the move is visible in the current price and intraday range.
What does today’s move show in Caplin Point Laboratories Share Price?
Ans. Today’s Caplin Point Laboratories Share Price move shows a Rs 55.95 rise from the previous close. The stock traded between Rs 2,585 and Rs 2,663.3, so the move remained contained within a clear range.
Is Caplin Point Laboratories a large company by market cap?
Ans. Caplin Point Laboratories has a market capitalisation of Rs 20,008.94 crore. In the same industry benchmark set, that is above the median and average, which gives Caplin Point Laboratories Share Price useful scale context.
How does Caplin Point Laboratories compare on valuation?
Ans. Caplin Point Laboratories Share Price carries a P/E of 29.74 and a P/B of 5.39. The P/E is below the same-industry median, while the P/B is above the median and above the industry average.
What do ROE and ROCE say about Caplin Point Laboratories?
Ans. Caplin Point Laboratories reports ROE of 20.79% and ROCE of 24.97%. Both are above the same-industry median and average, which adds important context to Caplin Point Laboratories Share Price and stock analysis.
Which Healthcare peers are most relevant for comparison?
Ans. Relevant peers include Sun Pharmaceutical, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Their market caps, P/E, P/B, ROE and ROCE make Caplin Point Laboratories Share Price easier to compare within Healthcare.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Caplin Point Laboratories Share Price on Univest for live price updates, Caplin Point Laboratories Share Price Today, valuation ratios, 52-week levels and market insights. Univest brings the current price, fundamentals, peer context and stock performance together so you can follow the same share price rise with a clear data-led view.
